SuperworthAlignment Healthcare EPS ALHC
Diluted earnings per share by quarter and over the last twelve months, from 2020.
- Last 12 months, to Jun 30, 2026
- $0.19
- Latest quarter, Q2 FY26
- $0.17
- +143% on a year earlier
- Fiscal year 2025
- −$0.01
Alignment Healthcare's earnings per share was $0.19 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was $0.17, up 143% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$0.01 | n/a |
| FY2024 | −$0.68 | n/a |
| FY2023 | −$0.79 | n/a |
| FY2021 | −$1.14 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.17 | +143% | $0.19 | |
| Q1 FY26 | $0.05 | n/a | $0.09 | |
| Q4 FY25 | −$0.05 | n/a | −$0.01 | |
| Q3 FY25 | $0.02 | n/a | −$0.12 | |
| Q2 FY25 | $0.07 | n/a | −$0.28 | |
| Q1 FY25 | −$0.05 | n/a | −$0.48 | |
| Q4 FY24 | −$0.16 | n/a | −$0.68 | |
| Q3 FY24 | −$0.14 | n/a | −$0.77 | |
| Q2 FY24 | −$0.13 | n/a | −$0.82 | |
| Q1 FY24 | −$0.25 | n/a | −$0.84 | |
| Q4 FY23 | −$0.25 | n/a | −$0.79 | |
| Q3 FY23 | −$0.19 | n/a | n/a |
Against its peers
Companies in Healthcare nearest Alignment Healthcare's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| ALHCAlignment Healthcare | $0.19 | |
| ANIPANI Pharmaceuticals | $4.70 | |
| ARDTArdent Health | $0.55 | −70% a year |
| HCSGHealthcare Services | $1.72 | +176% a year |
| PAHCPhibro Animal Health | $2.44 | +107% a year |
| EYENational Vision | $0.61 | |
| CNMDCONMED | $1.85 | −48% a year |
| PNTGPennant | $0.90 | +15% a year |
| ANABAnaptysbio | $4.57 | |
| PCRXPacira BioSciences | $0.35 | |
| LMATLemaitre Vascular | $2.85 | +38% a year |
| Peer median | $1.78 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Alignment Healthcare
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.